Circadian dysfunction in response to in vivo treatment with the mitochondrial toxin 3-nitropropionic acid

Autor: Dawn H. Loh, Takashi Kudo, Yu Tahara, Daniel D. Truong, Elizabeth Hernández-Echeagaray, Christopher S. Colwell
Rok vydání: 2013
Předmět:
Male
medicine.medical_specialty
Patch-Clamp Techniques
DD
constant dark

Circadian clock
Respiratory chain
Convulsants
Mitochondrion
Biology
S3
lcsh:RC321-571
Mice
suprachiasmatic
Internal medicine
Circadian Clocks
medicine
Animals
HD
Huntingon’s disease

Circadian rhythm
Gene Knock-In Techniques
DIC
differential interference contrast

lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry
PD
Parkinson’s disease

LD
light-dark

SCN
suprachiasmatic nucleus

SFR
spontaneous firing rate

Suprachiasmatic nucleus
3-NP
3-nitropropionic acid

General Neuroscience
Period Circadian Proteins
i.p.
intraperitoneally

Nitro Compounds
Pathophysiology
Mitochondria
PER2
Mice
Inbred C57BL

clock
Endocrinology
Huntington Disease
circadian
CT
circadian time

ZT
Zeitgeber time

Suprachiasmatic Nucleus
Neurology (clinical)
Propionates
Sleep
ACSF
artificial CSF (cerebrospinal fluid)

Research Article
Zdroj: ASN NEURO
ASN Neuro, Vol 6 (2013)
ISSN: 1759-0914
Popis: Sleep disorders are common in neurodegenerative diseases including Huntington's disease (HD) and develop early in the disease process. Mitochondrial alterations are believed to play a critical role in the pathophysiology of neurodegenerative diseases. In the present study, we evaluated the circadian system of mice after inhibiting mitochondrial complex II of the respiratory chain with the toxin 3-nitropropionic acid (3-NP). We found that a subset of mice treated with low doses of 3-NP exhibited severe circadian deficit in behavior. The temporal patterning of sleep behavior is also disrupted in some mice with evidence of difficulty in the initiation of sleep behavior. Using the open field test during the normal sleep phase, we found that the 3-NP-treated mice were hyperactive. The molecular clockwork responsible for the generation of circadian rhythms as measured by PER2::LUCIFERASE was disrupted in a subset of mice. Within the SCN, the 3-NP treatment resulted in a reduction in daytime firing rate in the subset of mice which had a behavioral deficit. Anatomically, we confirmed that all of the treated mice showed evidence for cell loss within the striatum but we did not see evidence for gross SCN pathology. Together, the data demonstrates that chronic treatment with low doses of the mitochondrial toxin 3-NP produced circadian deficits in a subset of treated mice. This work does raise the possibility that the neural damage produced by mitochondrial dysfunction can contribute to the sleep/circadian dysfunction seen so commonly in neurodegenerative diseases.
Databáze: OpenAIRE